早期使用小剂量多巴胺联合呋塞米治疗心力衰竭患者的临床有效性及安全性分析被引量：4

下载PDF

导出

摘要目的探讨早期使用小剂量多巴胺联合呋塞米治疗心力衰竭患者的应用效果。方法选取我院2017年3月至2018年3月治疗的150例心力衰竭患者为研究对象,均分为两组,对照组为呋塞米,观察组为早期使用小剂量多巴胺联合呋塞米,对比两组治疗情况。结果观察组的不良反应发生率5.33%与对照组的4.00%比较,统计学无意义(P>0.05);观察组的总有效率93.33%高于对照组的80.00%,统计学有意义(P<0.05)。结论早期使用小剂量多巴胺联合呋塞米治疗心力衰竭患者的应用效果显著,安全性高,提高了治疗效果,值得应用。

作者王亮

机构地区辽宁省葫芦岛市绥中县医院心血管内科

出处《中国医药指南》 2019年第26期74-75,共2页 Guide of China Medicine

关键词小剂量多巴胺呋塞米心力衰竭有效性安全性

分类号 R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献6

1张慧,蔡尚郎,姜先雁,蒋文彬,杨春悦.50%葡萄糖静注联合呋塞米治疗顽固性心力衰竭疗效分析[J].现代生物医学进展,2016,16(4):705-708. 被引量：6
2王爱华,廖荣宏,王静.呋塞米联合小剂量多巴胺治疗失代偿性心力衰竭的Meta分析[J].重庆医学,2016,45(14):1934-1936. 被引量：23
3邹云丞,吕云,高彦,白洁,李易.重组人脑利钠肽联合多巴胺治疗老年急性心力衰竭合并低血压的临床观察[J].中华老年心脑血管病杂志,2016,18(7):684-687. 被引量：38
4刘艳娜,李晓东,张琼,于天开,杨攀.左西孟旦联合呋塞米治疗顽固性心力衰竭的疗效分析[J].现代生物医学进展,2017,17(6):1149-1151. 被引量：8
5陆千军.硝普钠联合多巴胺对急性心力衰竭患者血流动力学和肾功能影响研究[J].陕西医学杂志,2017,46(1):105-108. 被引量：47
6全金龙.多巴胺联合酚妥拉明对小儿肺炎合并心力衰竭的疗效及心肌酶的影响[J].医学临床研究,2015,32(1):129-131. 被引量：28

二级参考文献49

1Lloyd-Jones D, Adams R,Carnethon M, et al. Heart dis- ease and stroke statistics-2009 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee[J]. Circulation, 2008,119 (3) :21-181.
2Gad C, Weissgarten J, Metzkor E, et al. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure[J]. Clin Pharmacol Ther, 1997,62(2) : 187-193.
3Giamouzis G,Butler J, Starling RC, et al. Impact of dopa- mine infusion on renal function in hospitalized heart fail- ure patients:results of the Dopamine inAcute Decompensated Heart Failure (DAD-HF) Trial [J]. J Card Fail,2010,16(12) :922-930.
4Shah RA, Subban V, Lakshmanan A, et al. A prospective, randomized study to evaluate the efficacy of various diu- retic strategies in acute decompensated heart failure[J]. Indian Heart J, 2014,66 (3). 309-316.
5Triposkiadis FK, Butler J, Karayannis G, et al. Efficacy and safety of high dose versus low dose furosemide with or with- out dopamine infusion:the Dopamine in Acute Decompensat- ed Heart Failure II(DAD- HF II) trial[J]. Int J Cardiol, 2014, 172(1) :115-121.
6Michael Felker G. Diuretic management in heart failure[J].Congest Heart Fail, 2010,16 Suppl 1 : S68-72.
7Krum HCP. Diuretics in the treatment of heart failure mainstay of therapy or potential hazard? [J]. J Card Fail, 2006,12 (5), 333-335.
8Chen HH, Anstrom KJ, Givertz MM, et al. Low-dose do- pamine or low-dose nesiritide in acute heart failure with renal dysfunctions the ROSE acute heart failure random- ized trial[J]. JAMA, 2013,310 (23) : 2533-2543.
9Torres-Courchoud I,Chen HH. Is there still a role for low- dose dopamine use in acute heart failure? [J]. Curr Opin Critl Care,2014,20(5) :467-471.
10Friedrich JO, Adhikari N, Herridge MS, et al. Meta-analysis: low-dose dopamine increases urine output but does not pre- vent renal dysfunction or death[J]. Ann Intern Med, 2005, 142(7) : 510-524.